Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-227-6 | CAS number: 12136-45-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Objective of study:
- absorption
- distribution
- excretion
- toxicokinetics
- Principles of method if other than guideline:
- citation of a summarizing review
- GLP compliance:
- not specified
- Radiolabelling:
- not specified
- Preliminary studies:
- Total body potassium is estimated to be approximately 135 g in a 70 kg adult man. Extracellular potassium (circa 2% of body pool) is important for regulation the membrane potential of the cells and thus for nerve and mscle function, blood pressure regulation, ...
Potassium also participates in the acid-base balance. 98% of the potassium in the body is found in the cells, where it is the main intracellular cation.
The absorption of potassium is effective and about 85-90% of dietary potassium is absorbed from the gut. The potassium balance is primarily regulated by renal excretion in urine.
The concentration of potassium in plasma is tightly regulated within a narrow range of about 3.5 to 5 mmol/L. The body is able to accommodate a high intake of potassium, without any substantial change in plasma concentration by synchronized alterations in both renal and extra-renal handling, with potassium either being excreted in the urine or taken up into cells. - Conclusions:
- Interpretation of results : no bioaccumulation potential based on study results
Potassium is an essential nutrient involved in fluid, acid and electrolyte balance and is required for normal cellular function. Dietary deficiency of potassium is very uncommon due to the widespread occurrence of potassium in foods. Available evidence suggests that potassium can modulate blood
pressure and increasing dietary potassium intake is associated with lower blood pressure. However, the available data are insufficient to establish a safe upper intake level for potassium. Based on estimates of current potassium intakes in European countries, the risk of adverse effects from potassium intake from food sources is considered to be low for the generally healthy population (children and adults). The average intake in adults from the diet is 3-4 g and the intake generally does not exceed 5-6 g per day. Total body potassium is estimated to be approximately 135 g in a 70 kg adult man.
Extracellular potassium (circa 2% of body pool) is important for regulation the membrane potential of the cells and thus for nerve and mscle function, blood pressure regulation, ...
Potassium also participates in the acid-base balance. 98% of the potassium in the body is found in the cells, where it is the main intracellular cation.
The absorption of potassium is effective and about 85-90% of dietary potassium is absorbed from the gut. The potassium balance is primarily regulated by renal excretion in urine.
The concentration of potassium in plasma is tightly regulated within a narrow range of about 3.5 to 5 mmol/L. The body is able to accommodate a high intake of potassium, without any substantial change in plasma concentration by synchronized alterations in both renal and extra-renal handling, with potassium either being excreted in the urine or taken up into cells.
Daily intakes of potassium from the habitual diet generally do not exceed 5-6 g/day and has not been associated with any negative effects in healthy individuals. Elderly people may be more vulnerable to potassium toxicity due to reduced physiological reserve in renal function. - Endpoint:
- dermal absorption in vivo
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- QSAR prediction:US EPA accepted QSAR method for chemicals properties assessment.
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Using the DERMWIN v2.01 QSAR model
- GLP compliance:
- no
- Remarks:
- not applicable to QSAR models
- Radiolabelling:
- no
- Species:
- other: QSAR model,
- Strain:
- other: QSAR model,
- Sex:
- not specified
- Type of coverage:
- other: QSAR model
- Vehicle:
- other: QSAR model
- Duration of exposure:
- not applicable to QSAR models
- Doses:
- not applicable to QSAR models
- No. of animals per group:
- not applicable to QSAR models
- Control animals:
- no
- Details on study design:
- not applicable to QSAR models
- Details on in vitro test system (if applicable):
- not applicable to QSAR models
- Signs and symptoms of toxicity:
- not specified
- Dermal irritation:
- not specified
- Absorption in different matrices:
- A QSAR model predicts that the permeability of Dipotassium oxide to human skin is quite low. The permeability coefficient was determined to be
0.000247 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=1.96e-007 cm/hr. - Conclusions:
- A QSAR model predicts that the permeability of Dipotassium oxide to human skin is quite low. The permeability coefficient was determined to be
0.000247 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=1.96e-007 cm/hr. - Executive summary:
A QSAR model predicts that the permeability of Dipotassium oxide to human skin is quite low. The permeability coefficient was determined to be 0.000247 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=1.96e-007 cm/hr.
Referenceopen allclose all
A QSAR model predicts that the permeability of Dipotassium oxide to human skin is quite low. The permeability coefficient was determined to be 0.000247 mg/cm2, which is around 1% of the skin penetration rate.
Predicted dermally absorbed coefficient was determined to be Kp (est)=1.96e-007 cm/hr.
Description of key information
Potassium oxide has not bioaccumulation potential.
Potassium is essential constituent and one of the most abundant ions in all animal species. In adult humans, the total body potassium is approx. 3.5 mol (135 g). 98 % of this is located intracellular (150 mmol/l), the extracellular potassium concentration is approx. 4 mmol/l.
Oxygen is the most abundant chemical element by mass in the Earth's biosphere, air, sea and land. Oxygen is the third most abundant chemical element in the universe, after hydrogen and helium
Both K+ and O- ions are normal constituents of the body fluids. K+ plays an essential role in the human physiology but starts to be toxic at levels exceeding 200 – 250 mg/l. Its concentration in the blood is regulated principally by renal excretion/reabsorption and controlled by an efficient feedback auto-regulation system. An excessive pH of the blood is prevented by the bicarbonate buffer system, respiration and renal compensation mechanisms.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - dermal (%):
- 1
Additional information
TOXICOKINETICS, METABOLISM, MECHANISMS OF ACTION
Potassium oxide is produced from the reaction of oxygen and potassium; this reaction affords potassium oxide, K2O.
Oxygen is the most abundant chemical element by mass in the Earth's biosphere, air, sea and land. Oxygen is the third most abundant chemical element in the universe, after hydrogen and helium
Potassium is essential constituent and one of the most abundant ions in all animal species. In adult humans, the total body potassium is approx. 3.5 mol (135 g). 98 % of this is located intracellular (150 mmol/l), the extracellular potassium concentration is approx. 4 mmol/l.
The metabolism and mechanisms of action of potassium is well reviewed in standard textbooks on pharmacology and physiology.
Metabolism, biotransformation and kinetics:
About 90 % of the ingested dose of potassium is absorbed by passive diffusion in the membrane of the upper intestine. Potassium is distributed to all tissues where it is the principal intracellular cation. Insulin, acid-base status, aldosterone, and adrenergic activity regulate cellular uptake of potassium.
The majority of ingested potassium is excreted in the urine via glomelural filtration. The distal tubules are able to secrete as well as reabsorb potassium, so they are able to produce a net secretion of potassium to achieve homeostasis in the face of a potassium load due to abnormally high levels of ingested potassium. About 15 % of the total amount of potassium excreted is found in faeces.
Excretion and retention of potassium is mainly regulated by the main adrenal cortical hormones.
Normal homeostatic mechanisms controlling the serum potassium levels allow a wide range of dietary intake. The renal excretory mechanism is designed for efficient removal of excess K, rather for its conservation during deficiency. Even with no intake of K, humans lose a minimum of 585- 1170 mg K per day. However, the distribution of potassium between the intracellular and the extracellular fluids can markedly affect the serum potassium level without a change in total body potassium.
Mechanisms of action:
K+ is the principal cation mediating the osmotic balance of the body fluids. In animals, the maintenance of normal cell volume and pressure depends on Na+ and K+ pumping. The K+/Na+ separation has allowed for evolution of reversible transmembrane electrical potentials essential for
nerve and muscle action in animals, and potassium is important in transmission of nerve impulses to the muscle fibers.
Potassium transport through the hydrofobic interior of a membrane can be facilitated by a number of natural compounds that form lipid-soluble alkali metal cation complexes. Potassium serves the critical role as counterion for various carboxylates, phosphates and sulphates, and stabilizes macromolecular structures.
Potassium is also important in the regulation of the acid-base balance of the body. Potassium is the principal base in tissues of blood cells.
Conclusion
Both K+ and O- ions are normal constituents of the body fluids. K+ plays an essential role in the human physiology but starts to be toxic at levels exceeding 200 – 250 mg/l. Its concentration in the blood is regulated principally by renal excretion/reabsorption and controlled by an efficient feedback auto-regulation system. An excessive pH of the blood is prevented by the bicarbonate buffer system, respiration and renal compensation mechanisms.
Potassium oxide has not bioaccumulation potential.
Potassium is essential constituent and one of the most abundant ions in all animal species. In adult humans, the total body potassium is approx. 3.5 mol (135 g). 98 % of this is located intracellular (150 mmol/l), the extracellular potassium concentration is approx. 4 mmol/l.
Oxygen is the most abundant chemical element by mass in the Earth's biosphere, air, sea and land. Oxygen is the third most abundant chemical element in the universe, after hydrogen and helium
Both K+ and O- ions are normal constituents of the body fluids. K+ plays an essential role in the human physiology but starts to be toxic at levels exceeding 200 – 250 mg/l. Its concentration in the blood is regulated principally by renal excretion/reabsorption and controlled by an efficient feedback auto-regulation system. An excessive pH of the blood is prevented by the bicarbonate buffer system, respiration and renal compensation mechanisms.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
